Release Date: 01/24/2017
After a rigorous national search, Paul A. DiSilvestro, MD, of Exeter, has been named the director of the Program in Women’s Oncology for Women & Infants Hospital of Rhode Island and Care New England Health System, and the division director for Gynecologic Oncology in the Department of Obstetrics and Gynecology at The Warren Alpert Medical School of Brown University.
Dr. DiSilvestro is a professor of obstetrics and gynecology at Brown and has been the interim director of the Program in Women’s Oncology and the Division of Gynecologic Oncology since April 2016.
“Dr. DiSilvestro is a trusted and steadfast leader presenting an exciting vision for the future, including development of a research program in developmental therapeutics as well as a personalized cancer medicine treatment program,” said Maureen G. Phipps, MD, MPH, chair and Chace-Joukowsky Professor of Obstetrics and Gynecology and assistant dean for Teaching and Research in Women’s Health at the Warren Alpert Medical School, professor of epidemiology at the Brown University School of Public Health, and chief of obstetrics and gynecology at Women & Infants Hospital and Care New England Health System. “With Dr. DiSilvestro’s leadership, we are well-positioned for an exciting future for our women’s oncology services at Women & Infants Hospital and across Care New England.”
Dr. DiSilvestro replaces Cornelius O. “Skip” Granai III, MD, FACOG, FACS, whose efforts brought the Program in Women’s Oncology into the national spotlight as an innovative center of cancer care excellence and who remains in a supportive emeritus role while continuing to see patients, train the next generation of women’s health providers, and provide outreach support.
Dr. DiSilvestro serves as the director of research in the Program in Women’s Oncology and the chair of the Board of Managers of the recently formed Care New England Medical Group (CNEMG). He is principal investigator for the Women & Infants Hospital site of the National Cancer Institute’s cooperative research group, NRG Oncology, the NIH-sponsored cancer collaborative that includes the Gynecologic Oncology Group. Dr. DiSilvestro is currently the co-chair of the Ovarian and Breast Cancer Committees at NRG Oncology and previously served on the Cancer Prevention and Control and the Phase I Committees. In addition, he has been study chair or co-chair of multiple National Cancer Institute-sponsored Gynecologic Oncology Group trials. Dr. DiSilvestro is well-respected nationally for his clinical, teaching and research expertise. He is a general board examiner as well as a subspecialty (gynecologic oncology) board examiner for the American Board of Obstetrics and Gynecology (ABOG).
A graduate of the University of Vermont College of Medicine, Dr. DiSilvestro completed a residency at Women & Infants Hospital and a fellowship in gynecologic oncology at the University of Oklahoma.
About Women & Infants Hospital
Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility. It is home to the nation’s first mother-baby perinatal psychiatric partial hospital, as well as the nation’s only fellowship program in obstetric medicine.
Women & Infants has been designated as a Breast Imaging Center of Excellence by the American College of Radiography; a Center of Excellence in Minimally Invasive Gynecology; a Center of Biomedical Research Excellence by the National Institutes of Health (NIH); and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute’s Gynecologic Oncology Group and the Pelvic Floor Disorders Network.